[PHARMA] QoQ Cumulative Quarter Result on 30-Jun-2020 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- 44.55%
YoY- 12.04%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 793,499 2,725,071 2,090,488 1,465,684 819,921 2,820,530 2,104,847 -47.78%
PBT 31,524 35,793 49,299 45,206 30,880 -191,865 46,609 -22.93%
Tax -8,696 -9,524 -15,983 -13,184 -8,465 42,418 -17,323 -36.81%
NP 22,828 26,269 33,316 32,022 22,415 -149,447 29,286 -15.28%
-
NP to SH 23,136 27,489 33,820 32,378 22,399 -149,219 29,379 -14.71%
-
Tax Rate 27.59% 26.61% 32.42% 29.16% 27.41% - 37.17% -
Total Cost 770,671 2,698,802 2,057,172 1,433,662 797,506 2,969,977 2,075,561 -48.30%
-
Net Worth 355,919 337,298 345,040 357,891 350,047 336,573 516,387 -21.95%
Dividend
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Div 10,468 28,761 26,139 22,204 15,673 22,177 22,168 -39.33%
Div Payout % 45.25% 104.63% 77.29% 68.58% 69.98% 0.00% 75.46% -
Equity
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Net Worth 355,919 337,298 345,040 357,891 350,047 336,573 516,387 -21.95%
NOSH 261,705 261,705 261,705 261,705 261,229 261,229 261,229 0.12%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 2.88% 0.96% 1.59% 2.18% 2.73% -5.30% 1.39% -
ROE 6.50% 8.15% 9.80% 9.05% 6.40% -44.33% 5.69% -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 303.20 1,042.20 799.75 561.06 313.87 1,081.04 807.07 -47.90%
EPS 8.84 10.51 12.94 12.39 8.57 -57.19 11.26 -14.88%
DPS 4.00 11.00 10.00 8.50 6.00 8.50 8.50 -39.47%
NAPS 1.36 1.29 1.32 1.37 1.34 1.29 1.98 -22.13%
Adjusted Per Share Value based on latest NOSH - 261,705
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 55.06 189.08 145.05 101.70 56.89 195.70 146.05 -47.78%
EPS 1.61 1.91 2.35 2.25 1.55 -10.35 2.04 -14.58%
DPS 0.73 2.00 1.81 1.54 1.09 1.54 1.54 -39.17%
NAPS 0.247 0.234 0.2394 0.2483 0.2429 0.2335 0.3583 -21.94%
Price Multiplier on Financial Quarter End Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 -
Price 3.26 5.00 4.32 2.22 1.26 2.06 2.44 -
P/RPS 1.08 0.48 0.54 0.40 0.40 0.19 0.30 134.70%
P/EPS 36.88 47.56 33.39 17.91 14.69 -3.60 21.66 42.54%
EY 2.71 2.10 2.99 5.58 6.81 -27.76 4.62 -29.90%
DY 1.23 2.20 2.31 3.83 4.76 4.13 3.48 -49.97%
P/NAPS 2.40 3.88 3.27 1.62 0.94 1.60 1.23 56.08%
Price Multiplier on Announcement Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 20/02/20 20/11/19 -
Price 4.03 3.49 5.72 4.42 1.88 2.04 2.21 -
P/RPS 1.33 0.33 0.72 0.79 0.60 0.19 0.27 189.22%
P/EPS 45.59 33.20 44.21 35.66 21.93 -3.57 19.62 75.34%
EY 2.19 3.01 2.26 2.80 4.56 -28.04 5.10 -43.05%
DY 0.99 3.15 1.75 1.92 3.19 4.17 3.85 -59.52%
P/NAPS 2.96 2.71 4.33 3.23 1.40 1.58 1.12 91.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment